416375002: Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorised by disposition\Tobramycin-containing product\...

\Tobramycin-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Loteprednol- and tobramycin-containing product\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Loteprednol- and tobramycin-containing product\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Medicinal product categorised by structure\Steroid-containing product\Androstane-containing product\Loteprednol-containing product\Loteprednol- and tobramycin-containing product\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Steroid-containing product\Androstane-containing product\Loteprednol-containing product\Loteprednol- and tobramycin-containing product\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Steroid-containing product\Androstane-containing product\Loteprednol-containing product\Loteprednol-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Glucocorticoid-containing product\Loteprednol-containing product\Loteprednol- and tobramycin-containing product\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Glucocorticoid-containing product\Loteprednol-containing product\Loteprednol- and tobramycin-containing product\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Glucocorticoid-containing product\Loteprednol-containing product\Loteprednol-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Tobramycin-containing product\Tobramycin-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Tobramycin-containing product\Loteprednol- and tobramycin-containing product\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Medicinal product categorised by structure\Glycoside-containing product\Aminoglycoside-containing product\Aminoglycoside antibacterial agent\Tobramycin-containing product\Loteprednol- and tobramycin-containing product\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Medicinal product categorised by therapeutic role\Antiinfective agent\Antibacterial agent\Aminoglycoside antibacterial agent\Tobramycin-containing product\...

\Tobramycin-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Loteprednol- and tobramycin-containing product\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Loteprednol- and tobramycin-containing product\Loteprednol and tobramycin only product\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

\Product manufactured as ocular dose form\Tobramycin-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension
\Product manufactured as ocular dose form\Loteprednol-containing product in ocular dose form\Loteprednol- and tobramycin-containing product in ocular dose form\Loteprednol and tobramycin only product in ocular dose form\Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym Active Initial character case insensitive SNOMED CT core

3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Count of base of active ingredient	2	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol and tobramycin only product in ocular dose form	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has precise active ingredient	Loteprednol etabonate	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has precise active ingredient	Tobramycin	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has BoSS	Tobramycin	true	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator value	5	false	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has concentration strength numerator value	3	false	Inferred relationship	Some	1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has BoSS	Loteprednol etabonate	true	Inferred relationship	Some	2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Plays role	Antibacterial therapeutic role	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol etabonate + tobramycin	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Corticosterone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Adrenal hormone agent	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Tobramycin	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Loteprednol etabonate	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Glucocorticoid hormone	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has active ingredient	Bactericide	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Ocular dose form	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol etabonate ophthalmic preparation	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Tobramycin in ophthalmic dosage form	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Has manufactured dose form	Eye suspension	true	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol- and tobramycin-containing product	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	Loteprednol-containing product in ocular dose form	false	Inferred relationship	Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3762275019	Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3762276018	Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core